NFKB1 and hepatocellular carcinoma: Therefore, NF-κB would be a useful therapeutic target and down-regulation of NF-κB's activation would be a useful strategy to overcome radioresistance of HCC cells and enhance the efficacy of radiotherapy in HCC treatment.